Table 2.
Cumulative negative conversion rates of SARS-CoV-2 RNA during treatment
| During treatment | Control group (n=368) | Treatment group (n=490) | P value |
|---|---|---|---|
| Cumulative negative conversion rates, No./Total (%) | |||
| At Day2 | 34/368 (9.24) | 68/490 (13.88) | 0.04* |
| At Day3 | 61/368 (16.58) | 158/490 (32.24) | <0.001*** |
| At Day4 | 133/368 (36.14) | 252/490 (51.43) | <0.001*** |
| At Day5 | 223/368 (60.60) | 322/490 (65.71) | 0.12 |
| At Day6 | 257/368 (69.84) | 381/490 (77.76) | 0.008** |
| At Day7 | 304/368 (82.61) | 427/490 (87.14) | 0.06 |
Note: The levels of SARS-CoV-2 RNA were tested by real-time PCR every day after patients were treated. The cumulative negative conversion rates of SARS-CoV-2 were recorded every day. *, P ≤0.05; **P ≤0.01; ***P ≤0.001.